jump to navigation

Kiran Mazumdar Shaw, Biocon at Great Lakes – Economic Times August 28, 2009

Posted by Manik Kinra in Uncategorized.
Tags: , ,
trackback

CHENNAI: Biocon’s chairman and managing director Kiran Mazumdar Shaw is betting big on the oral insulin drug that the company is scheduled to Kiran Mazumdar Shaw, Chairman and Managing Director, Biocon unveil next March. Now that the markets are picking up, she also said the firm would look at listing its research division Syngene. Dr Shaw spoke to ET NOW on the sidelines of a seminar organised by the Great Lakes Institute of Management, where she shared her experiences in setting up and growing Biocon with the B-school.

Read the complete interview at http://economictimes.indiatimes.com/Interview/Kiran-Mazumdar-Shaw-Chairman-and-Managing-Director-Biocon/articleshow/4937957.cms

Comments»

No comments yet — be the first.